SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-22-290962 from Orthofix Medical Inc. (OFIX) (CIK 0000884624) (OFIX)

Orthofix Medical Inc. (OFIX) (CIK 0000884624)
Date: Nov. 22, 2022 · CIK: 0000884624 · Accession: 0001193125-22-290962

AI Filing Summary & Sentiment

File numbers found in text: 333-268234

Date
November 22, 2022
Author
By
Form
CORRESP
Company
Orthofix Medical Inc. (OFIX) (CIK 0000884624)

Letter

VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Washington, D.C. 20549 Re: Orthofix Medical Inc. Registration Statement on Form S-4 (File No. 333-268234) Request for Acceleration of Effective Date

Dear Ms. Abby Adams:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Orthofix Medical Inc. (the “Company”) hereby respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date and time of the above referenced Registration Statement on Form S-4 (the “Registration Statement”) and declare the Registration Statement effective as of 5:30 p.m. Eastern Time on November 22, 2022, or as soon thereafter as practicable.

The Company requests that it be notified of such effectiveness by a telephone call to Joseph E. Gilligan of Hogan Lovells US LLP at (202) 637-5945.

[Signature page follows]

Sincerely,
Orthofix Medical Inc.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Orthofix Medical Inc.

3451 Plano Parkway

 Lewisville,
Texas 75056

 November 22, 2022

 VIA EDGAR

U.S. Securities and Exchange Commission

 Division of Corporation
Finance

 Office of Industrial Applications and Services

 100
F Street, N.E.

 Washington, D.C. 20549

Re:
 Orthofix Medical Inc.

Registration Statement on Form S-4 (File No. 333-268234)

Request for Acceleration of Effective Date

Dear Ms. Abby Adams:

 Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Orthofix Medical Inc. (the “Company”) hereby respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date and
time of the above referenced Registration Statement on Form S-4 (the “Registration Statement”) and declare the Registration Statement effective as of 5:30 p.m. Eastern Time on
November 22, 2022, or as soon thereafter as practicable.

 The Company requests that it be notified of such effectiveness by a
telephone call to Joseph E. Gilligan of Hogan Lovells US LLP at (202) 637-5945.

 [Signature page
follows]

Sincerely,

Orthofix Medical Inc.

By:

/s/ Kimberley A. Elting

Kimberley A. Elting

Chief Legal and Development Officer and President, Global Orthopedics